REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 52 filers reported holding REGULUS THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $78,000 | -26.4% | 47,100 | 0.0% | 0.00% | – |
| Q4 2016 | $106,000 | -31.6% | 47,100 | 0.0% | 0.00% | – |
| Q3 2016 | $155,000 | +14.0% | 47,100 | 0.0% | 0.00% | – |
| Q2 2016 | $136,000 | -11.7% | 47,100 | +112.2% | 0.00% | – |
| Q1 2016 | $154,000 | -20.6% | 22,200 | 0.0% | 0.00% | – |
| Q4 2015 | $194,000 | +37.6% | 22,200 | +2.8% | 0.00% | – |
| Q3 2015 | $141,000 | -40.5% | 21,600 | 0.0% | 0.00% | – |
| Q2 2015 | $237,000 | -35.2% | 21,600 | 0.0% | 0.00% | – |
| Q1 2015 | $366,000 | +3227.3% | 21,600 | +2985.7% | 0.00% | – |
| Q4 2014 | $11,000 | +120.0% | 700 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | -54.5% | 700 | -50.0% | 0.00% | – |
| Q2 2014 | $11,000 | +1000.0% | 1,400 | +827.2% | 0.00% | – |
| Q1 2014 | $1,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | -98.4% | 151 | -97.7% | 0.00% | – |
| Q3 2013 | $61,000 | -29.1% | 6,451 | -26.0% | 0.00% | – |
| Q2 2013 | $86,000 | – | 8,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |